ARID1A and cancer: A previous study reported that ARID1A activity was correlated with p-AKT signals in cancers [28,29], and the key components of the phosphatidylinositol 3-kinase (PI3K) pathway were often either mutated or dysregulated in SCLC (Fig. S6A and B).